Invest Different
Results 1 - 10 of 121 : 1 2 3 4 5 6 7 8 9 Next
1 Reason the Street Should Expect Big Things From Endo Pharmaceuticals Holdings
Don’t just ask, “How much inventory?” Ask, “What kind?”
Why Endo Pharmaceuticals' Earnings Are Outstanding
All cash flow is not created equal.
Endo Pharmaceuticals Earnings Preview
Endo Pharmaceuticals will unveil its latest earnings on Thursday, Oct. 27.
Checking the Quality of Hospira's Growth
These two simple metrics can save you a lot of pain.
Let's Check the Quality of Jazz Pharmaceuticals' Growth
These two simple metrics can save you a lot of pain.
About That Developing Technology...
Sangamo's diabetic neuropathy drug, SB-509, fails to impress.
5-Star Stocks Poised to Pop: Endo Pharmaceuticals
Market-trouncing returns could be written in this five-star.
Why the Future Looks Bright for Endo Pharmaceuticals
Don't just ask, "How much inventory?" Ask, "What kind?"
The 20 Fastest Growers in Pharma
Yesterday's proven track records may reveal tomorrow's winners.
Does Antares Pharma Miss the Grade?
Keep your eye on margins.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK